- Home
- Software Solutions
- Resources
- Corporate
A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma
Sponsors:
| Phases:
| |
| Indications | Acronym: OCEANS | |
| ||
Age Groups:
| Gender: Female | |
Names:
| Enrollment: 450 | |
Additional information about NCT00434642.